Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana ...

Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...

The Biognosys Group, a leader in mass spectrometry-based multiomics, announces advancements across its integrated multiomics ...

Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for PT-141 peptide reference material, provided strictly for laboratory developmental ...

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

The increase in the number of users, hospitalizations and deaths due to overdose of synthetic opioids made the scientific community to treat this problem as “the opioid crisis”, justifying the need ...

LYON, France--(BUSINESS WIRE)--Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the ...

1 Clinical Laboratory, Baise Second People’s Hospital, Baise, China. 2 Clinical Laboratory, Guangxi-ASEAN Technological Development Zone People’s Hospital (The Tenth People’s Hospital of Nanning), ...

The pharmacological profile of LDX is characterized by its inactive state until metabolized to d-amphetamine, which exerts the therapeutic effects. d-Amphetamine, a potent non-catecholamine ...

Department of Drug Metabolism and Pharmacokinetics, and Modeling, Takeda Development Center Americas, Incorporation, 35 Landsdowne Street, Cambridge, Massachusetts 02139, United States ...